Global Oral Proteins and Peptides Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
Description
According to our (Global Info Research) latest study, the global Oral Proteins and Peptides market size was valued at US$ 2783 million in 2025 and is forecast to a readjusted size of US$ 7302 million by 2032 with a CAGR of 14.9% during review period.
Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention, treatment and diagnosis. Polypeptide is a compound formed by linking α-amino acids together with a peptide chain, and it is also an intermediate product of proteolysis. N polypeptide chains are entangled in a certain spatial structure to form a protein. The hydrolysis of macromolecular proteins produces polypeptides. Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.
With the breakthrough of delivery technology, oral alternatives to injections have become a new trend, improving patient compliance and driving market growth.
The demand for oral protein and peptide drugs for the treatment of chronic diseases (such as diabetes and inflammatory bowel disease) continues to rise.
Nano-delivery systems and enzyme inhibition encapsulation technologies continue to mature, solving gastrointestinal degradation problems and expanding product development space.
Many biopharmaceutical companies around the world are advancing clinical trials and cooperative development to accelerate the commercialization process.
Despite regulatory challenges and cost pressures, the oral protein/peptide market is still seen as a high-potential blue ocean track.
This report is a detailed and comprehensive analysis for global Oral Proteins and Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oral Proteins and Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/kg), 2021-2032
Global Oral Proteins and Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/kg), 2021-2032
Global Oral Proteins and Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/kg), 2021-2032
Global Oral Proteins and Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Proteins and Peptides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Proteins and Peptides market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Oral Proteins and Peptides market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Market segment by Application
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Major players covered
Ironwood & Allergan (AbbVie)
Novo Nordisk
Synergy Pharmaceuticals (Salix)
Novartis
Chiasma (Amryt Pharma)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Proteins and Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Proteins and Peptides, with price, sales quantity, revenue, and global market share of Oral Proteins and Peptides from 2021 to 2026.
Chapter 3, the Oral Proteins and Peptides competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Proteins and Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Oral Proteins and Peptides market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Proteins and Peptides.
Chapter 14 and 15, to describe Oral Proteins and Peptides sales channel, distributors, customers, research findings and conclusion.
Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention, treatment and diagnosis. Polypeptide is a compound formed by linking α-amino acids together with a peptide chain, and it is also an intermediate product of proteolysis. N polypeptide chains are entangled in a certain spatial structure to form a protein. The hydrolysis of macromolecular proteins produces polypeptides. Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.
With the breakthrough of delivery technology, oral alternatives to injections have become a new trend, improving patient compliance and driving market growth.
The demand for oral protein and peptide drugs for the treatment of chronic diseases (such as diabetes and inflammatory bowel disease) continues to rise.
Nano-delivery systems and enzyme inhibition encapsulation technologies continue to mature, solving gastrointestinal degradation problems and expanding product development space.
Many biopharmaceutical companies around the world are advancing clinical trials and cooperative development to accelerate the commercialization process.
Despite regulatory challenges and cost pressures, the oral protein/peptide market is still seen as a high-potential blue ocean track.
This report is a detailed and comprehensive analysis for global Oral Proteins and Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oral Proteins and Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/kg), 2021-2032
Global Oral Proteins and Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/kg), 2021-2032
Global Oral Proteins and Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/kg), 2021-2032
Global Oral Proteins and Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Proteins and Peptides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Proteins and Peptides market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Oral Proteins and Peptides market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Market segment by Application
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Major players covered
Ironwood & Allergan (AbbVie)
Novo Nordisk
Synergy Pharmaceuticals (Salix)
Novartis
Chiasma (Amryt Pharma)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Proteins and Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Proteins and Peptides, with price, sales quantity, revenue, and global market share of Oral Proteins and Peptides from 2021 to 2026.
Chapter 3, the Oral Proteins and Peptides competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Proteins and Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Oral Proteins and Peptides market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Proteins and Peptides.
Chapter 14 and 15, to describe Oral Proteins and Peptides sales channel, distributors, customers, research findings and conclusion.
Table of Contents
73 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Oral Proteins and Peptides by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
